{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:52:22Z","timestamp":1772711542102,"version":"3.50.1"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semcancer.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T14:07:41Z","timestamp":1558534061000},"page":"122-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The antigenic link between thyroid autoimmunity and breast cancer"],"prefix":"10.1016","volume":"64","author":[{"given":"Ilaria","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Barrett-Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2019.05.013_bib0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(75)91006-5","article-title":"Breast cancer in patients with Hashimoto\u2019s thyroiditis","volume":"2","author":"Ito","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0010","first-page":"553","article-title":"Thyroid function in patients with breast cancer. J. Cancer Clin","volume":"23","author":"Rasmusson","year":"1987","journal-title":"Oncol ."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0015","first-page":"504","article-title":"Thyroid disorders and breast cancer","volume":"5","author":"Shering","year":"1996","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0020","first-page":"990","article-title":"Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy","volume":"81","author":"Giani","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0025","first-page":"2711","article-title":"Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma","volume":"83","author":"Smyth","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/ejso.2001.1204","article-title":"Autoimmune thyroid disease in women with breast carcinoma","volume":"27","author":"Gogas","year":"2001","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0035","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/bcr609","article-title":"Breast cancer in association with thyroid disorders","volume":"5","author":"Turken","year":"2003","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0040","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/thy.2005.15.1253","article-title":"Hypothyroidism might be related to breast cancer in post-menopausal women","volume":"15","author":"Kuijpens","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.02108","article-title":"Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery","volume":"154","author":"Giustarini","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0050","first-page":"1603","article-title":"Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival","volume":"18","author":"Jiskra","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0055","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10549-012-2019-3","article-title":"Benign thyroid disease is associated with breast cancer: a meta-analysis","volume":"133","author":"Hardefeldt","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-014-2893-y","article-title":"Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients","volume":"144","author":"Prinzi","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03347458","article-title":"High prevalence of breast cancer in patients with benign thyroid diseases","volume":"34","author":"Muller","year":"2011","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122958","article-title":"Association of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients","volume":"10","author":"Prinzi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.1.6004.257","article-title":"Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer","volume":"1","author":"Mittra","year":"1976","journal-title":"Br. Med. J."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0080","first-page":"263","article-title":"Hashimoto\u2019s thyroiditis and breast cancer","volume":"51","author":"Maruchi","year":"1976","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(81)92890-7","article-title":"Thyroid disease and breast cancer","volume":"1","author":"Hedley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14310\/horm.2002.1152","article-title":"Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis","volume":"1","author":"Sarlis","year":"2002","journal-title":"Hormones Athens (Athens)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0095","first-page":"1574","article-title":"Do thyroid disorders increase the risk of breast cancer?","volume":"11","author":"Simon","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0100","first-page":"425","article-title":"Breast cancer in association with thyroid disorders","volume":"14","author":"Michalaki","year":"2009","journal-title":"J. BUON"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.60.5.433","article-title":"Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies","volume":"60","author":"Abu-Shakra","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0115","series-title":"Thyroid, Williams Textbook of Endocrinology","first-page":"327","author":"Melmed","year":"2012"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrendo.2015.66","article-title":"Thyroid hormone transporters--functions and clinical implications","volume":"11","author":"Bernal","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0125","first-page":"673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0130","series-title":"Ontogeny, Anatomy, Metabolism and Physiology of the Thyroid","author":"Dumont","year":"2000"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0135","series-title":"Hypothalamus and Pituitary, Williams Textbook of Endocrinology","first-page":"115","author":"Melmed","year":"2012"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0140","first-page":"144","article-title":"Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus","volume":"168","author":"Lechan","year":"1992","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0145","series-title":"Stevens & Lowe\u2019s Human Histology","first-page":"378","author":"Lowe","year":"2015"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0150","series-title":"Physiology and Function of the Breast","first-page":"45","author":"Donegan","year":"2002"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0155","series-title":"Breastfeeding, Infant and Young Child Feeding: Model Chapter for Textbooks for Medical Students and Allied Health Professionals","first-page":"9","author":"WHO","year":"2009"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0160","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0300-9084(78)80027-3","article-title":"Post-transcriptional stimulation of casein synthesis by thyroid hormone","volume":"60","author":"Houdebine","year":"1978","journal-title":"Biochimie"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1210\/endo-104-2-409","article-title":"Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones","volume":"104","author":"Vonderhaar","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0170","first-page":"1030","article-title":"Nuclear thyroid hormone receptors in C3H\/HeN mouse mammary glands and spontaneous tumors","volume":"43","author":"Sellitti","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/annonc\/mdj040","article-title":"Influence of thyroid hormone receptors on breast cancer cell proliferation","volume":"17","author":"Conde","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(96)00117-3","article-title":"Triiodothyronine mimics the effects of estrogen in breast cancer cell lines","volume":"59","author":"Nogueira","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(02)00614-6","article-title":"Thyroid hormone receptors\/THR genes in human cancer","volume":"192","author":"Gonzalez-Sancho","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2007.12.008","article-title":"Effects of thyroid hormones on human breast cancer cell proliferation","volume":"109","author":"Hall","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0195","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/ERC-12-0219","article-title":"Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective","volume":"20","author":"Moeller","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0200","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jcem.86.7.7641","article-title":"Clinical review 132: the sodium iodide symporter and its potential role in cancer therapy","volume":"86","author":"Spitzweg","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10911-005-5401-5","article-title":"Is iodine a gatekeeper of the integrity of the mammary gland?","volume":"10","author":"Aceves","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/biof.5520190304","article-title":"Role of iodine in antioxidant defence in thyroid and breast disease","volume":"19","author":"Smyth","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0215","first-page":"1245","article-title":"Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer","volume":"85","author":"Kilbane","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-008-0104-4","article-title":"Autoimmune hypothyroidism and breast cancer in the elderly","volume":"115","author":"Sandhu","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02788999","article-title":"Different tissue responses for iodine and iodide in rat thyroid and mammary glands","volume":"49","author":"Eskin","year":"1995","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0230","first-page":"937","article-title":"A direct relationship between thyroid enlargement and breast cancer","volume":"81","author":"Smyth","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Frohlich","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0245","first-page":"192","article-title":"The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease","volume":"13","author":"McLachlan","year":"1992","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0250","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1093\/nar\/15.16.6735","article-title":"Complete nucleotide sequence of the human thyroperoxidase-microsomal antigen cDNA","volume":"15","author":"Libert","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0255","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1002\/j.1460-2075.1987.tb02766.x","article-title":"Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules","volume":"6","author":"Libert","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0260","series-title":"Peroxidases and Catalases","year":"1973"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-2797(00)00201-5","article-title":"Peroxidases","volume":"129","author":"O\u2019Brien","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0270","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.freeradbiomed.2008.09.009","article-title":"Identification and characterization of VPO1, a new animal heme-containing peroxidase","volume":"45","author":"Cheng","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.abb.2005.09.017","article-title":"Active site structure and catalytic mechanisms of human peroxidases","volume":"445","author":"Furtmuller","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0280","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1089\/thy.2007.0169","article-title":"Thyroid peroxidase as an autoantigen","volume":"17","author":"McLachlan","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0285","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1073\/pnas.84.16.5555","article-title":"Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs","volume":"84","author":"Kimura","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0290","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0006-291X(90)92152-P","article-title":"Evidence for an alternate splicing in the thyroperoxidase messenger from patients with Graves\u2019 disease","volume":"170","author":"Zanelli","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0295","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M209513200","article-title":"Increasing diversity of human thyroperoxidase generated by alternative splicing. Characterized by molecular cloning of new transcripts with single- and multispliced mRNAs","volume":"278","author":"Ferrand","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0300","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1021\/bi0026324","article-title":"Alternatively spliced form of human thyroperoxidase, TPOzanelli: activity, intracellular trafficking, and role in hormonogenesis","volume":"40","author":"Niccoli-Sire","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0305","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.28493","article-title":"Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer?","volume":"134","author":"Muller","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0310","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biochi.2019.02.003","article-title":"Thyroid peroxidase as a dual active site enzyme: focus on biosynthesis, hormonogenesis and thyroid disorders of autoimmunity and cancer","volume":"160","author":"Godlewska","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08916939209148468","article-title":"Analysis of carbohydrate residues on human thyroid peroxidase (TPO) and thyroglobulin (Tg) and effects of deglycosylation, reduction and unfolding on autoantibody binding","volume":"12","author":"Kiso","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0320","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0303-7207(95)03680-6","article-title":"The thyroperoxidase doublet is not produced by alternative splicing","volume":"115","author":"Cetani","year":"1995","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-5793(85)80446-4","article-title":"Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases","volume":"190","author":"Czarnocka","year":"1985","journal-title":"FEBS Lett."},{"issue":"87","key":"10.1016\/j.semcancer.2019.05.013_bib0330","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, t(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III)","author":"Hollowell","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0335","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2265.2010.03855.x","article-title":"Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum","volume":"74","author":"Weetman","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0345","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0140-6736(60)92842-7","article-title":"Thyrogloubulin antibodies in patients without clinical disease of the thyroid gland","volume":"2","author":"Hackett","year":"1960","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0350","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02879477","article-title":"Immunological status of aged subjects with reference to serological evidence of autoimmunity","volume":"7","author":"Zanussi","year":"1977","journal-title":"Ric. Clin. Lab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0355","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmj.282.6260.258","article-title":"Natural history of autoimmune thyroiditis","volume":"282","author":"Tunbridge","year":"1981","journal-title":"Br. Med. J. Clin. Res. Ed (Clin Res Ed)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0360","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2265.2011.04008.x","article-title":"A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population","volume":"75","author":"Pedersen","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0365","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/08916939409014677","article-title":"Iodide induced lymphocytic thyroiditis in the BB\/W rat: evidence of direct toxic effects of iodide on thyroid subcellular structure","volume":"18","author":"Li","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0370","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1016\/S0021-9258(17)44635-7","article-title":"The role of iodination in the formation of hormone-rich peptides from thyroglobulin","volume":"258","author":"Dunn","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2249.1998.00643.x","article-title":"Iodination of human thyroglobulin (Tg) alters its immunoreactivity. I. Iodination alters multiple epitopes of human Tg","volume":"113","author":"Saboori","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0380","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/jcem-68-6-1091","article-title":"Antibodies to human thyroid peroxidase in autoimmune thyroid disease: studies with a cloned recombinant complementary deoxyribonucleic acid epitope","volume":"68","author":"Ludgate","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0385","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-4157(93)90017-I","article-title":"Iodide transport in the thyroid gland","volume":"1154","author":"Carrasco","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0390","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0395","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/eje.0.1320399","article-title":"Identification of the thyroid Na+\/I- cotransporter as a potential autoantigen in thyroid autoimmune disease","volume":"132","author":"Raspe","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0400","first-page":"1217","article-title":"The modulation of the human sodium iodide symporter activity by Graves\u2019 disease sera","volume":"83","author":"Ajjan","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0405","first-page":"2020","article-title":"Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease","volume":"85","author":"Ajjan","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0410","first-page":"3937","article-title":"Rarity of anti- Na+\/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD)","volume":"85","author":"Chin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0415","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/eje.0.1440611","article-title":"Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells","volume":"144","author":"Tonacchera","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0420","first-page":"4630","article-title":"Low frequency of autoantibodies to the human Na(+)\/I(-) symporter in patients with autoimmune thyroid disease","volume":"85","author":"Seissler","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0425","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cen.12434","article-title":"Pendrin and NIS antibodies are absent in healthy individuals and are rare in autoimmune thyroid disease: evidence from a Danish twin study","volume":"81","author":"Brix","year":"2014","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40618-015-0368-6","article-title":"The sodium iodide symporter is unlikely to be a thyroid\/breast shared antigen","volume":"39","author":"Muller","year":"2016","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0435","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0445","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.2008.03338.x","article-title":"The incidence of autoimmune thyroid disease: a systematic review of the literature","volume":"69","author":"McGrogan","year":"2008","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtbi.2014.12.015","article-title":"Thyroid autoimmunity as a window to autoimmunity: an explanation for sex differences in the prevalence of thyroid autoimmunity","volume":"375","author":"Merrill","year":"2015","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0455","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0002-9440(10)61762-2","article-title":"Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers","volume":"159","author":"Armengol","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0460","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.4049\/jimmunol.170.12.6320","article-title":"Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases","volume":"170","author":"Armengol","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0465","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/jc.2011-1568","article-title":"Innate immune activation and thyroid autoimmunity","volume":"96","author":"Kawashima","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004123","article-title":"Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease","volume":"10","author":"Medici","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0475","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0480","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/08916934.2010.518575","article-title":"Monozygotic twin pairs discordant for Hashimoto\u2019s thyroiditis share a high proportion of thyroid peroxidase autoantibodies to the immunodominant region A. Further evidence for genetic transmission of epitopic \"fingerprints\"","volume":"44","author":"Brix","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0485","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jcem.87.7.8678","article-title":"Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies","volume":"87","author":"Huber","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0490","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clim.2009.07.014","article-title":"A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase","volume":"133","author":"Nielsen","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0495","first-page":"2595","article-title":"Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies","volume":"81","author":"Rodien","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0500","first-page":"1700","article-title":"Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis","volume":"77","author":"Chiovato","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0505","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ncpendmet0846","article-title":"The role of thyroid autoimmunity in fertility and pregnancy","volume":"4","author":"Poppe","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0510","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.beem.2011.07.010","article-title":"Thyroid disease in pregnancy","volume":"25","author":"Negro","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0515","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(74)91815-7","article-title":"Thyroid-stimulating immunoglobulins in Graves\u2019 disease","volume":"2","author":"Smith","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0520","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed graves\u2019 hyperthyroidism seen at a single center","volume":"98","author":"Tanda","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0530","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1530\/EJE-15-1164","article-title":"THERAPY OF ENDOCRINE DISEASE: endocrine dilemma: management of graves\u2019 orbitopathy","volume":"175","author":"Campi","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0535","series-title":"Graves\u2019 Disease and the Manifestations of Thyrotoxicosis","author":"DeGroot","year":"2000"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0540","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2265.2003.01862.x","article-title":"Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease","volume":"59","author":"Strieder","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0545","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","article-title":"Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms","volume":"29","author":"Huber","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0550","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/eje.0.1500605","article-title":"The environment and autoimmune thyroid diseases","volume":"150","author":"Prummel","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0555","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ecl.2007.07.001","article-title":"Interferon alpha treatment and thyroid dysfunction","volume":"36","author":"Tomer","year":"2007","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0560","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","article-title":"The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology","volume":"30","author":"Jacobson","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0565","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/426947","article-title":"Regression mapping of association between the human leukocyte antigen region and Graves disease","volume":"76","author":"Simmonds","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0570","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/hmg\/ddm165","article-title":"A novel and major association of HLA-C in Graves\u2019 disease that eclipses the classical HLA-DRB1 effect","volume":"16","author":"Simmonds","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0575","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","article-title":"A molecular perspective of CTLA-4 function","volume":"24","author":"Teft","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0580","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smim.2009.05.008","article-title":"Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis","volume":"21","author":"Munroe","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0585","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of the TSHR","volume":"322","author":"Brand","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0590","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","article-title":"Immunogenetics of autoimmune thyroid diseases: a comprehensive review","volume":"64","author":"Lee","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083811","article-title":"Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients","volume":"8","author":"Cerosaletti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0600","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2265.2007.02762.x","article-title":"Association of the interleukin-2 receptor alpha (IL-2Ralpha)\/CD25 gene region with Graves\u2019 disease using a multilocus test and tag SNPs","volume":"66","author":"Brand","year":"2007","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0605","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1210\/jc.2012-2408","article-title":"Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes","volume":"98","author":"Tomer","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0610","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.ejhg.5201485","article-title":"Association of the TSHR gene with Graves\u2019 disease: the first disease specific locus","volume":"13","author":"Dechairo","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0615","doi-asserted-by":"crossref","first-page":"E799","DOI":"10.1210\/jc.2014-4352","article-title":"A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations","volume":"100","author":"Schultheiss","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0620","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1038\/s41467-018-06356-1","article-title":"Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation","volume":"9","author":"Teumer","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0625","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-01551","article-title":"A weighted genetic risk score using known susceptibility variants to predict Graves\u2019 disease risk","author":"Ma","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0630","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/BOR.0b013e3283389641","article-title":"What can we learn from epigenetics in the year 2009?","volume":"22","author":"Jungel","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0635","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0640","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1038\/s41598-018-26700-1","article-title":"Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves\u2019 disease and orbitopathy","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0645","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/jaut.2000.0482","article-title":"Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals","volume":"16","author":"Fournie","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0650","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/JCM.00312-06","article-title":"Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn\u2019s disease","volume":"44","author":"Scanlan","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0655","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025792","article-title":"Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes","volume":"6","author":"Brown","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0665","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1741-7015-11-46","article-title":"Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study","volume":"11","author":"Murri","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0670","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-6-5","article-title":"Viruses and thyroiditis: an update","volume":"6","author":"Desailloud","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0675","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","article-title":"The etiology of autoimmune thyroid disease: a story of genes and environment","volume":"32","author":"Tomer","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0680","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0685","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/a-0653-3766","article-title":"Gut microbiome in BALB\/c and C57BL\/6J mice undergoing experimental thyroid autoimmunity associate with differences in immunological responses and thyroid function","volume":"50","author":"Moshkelgosha","year":"2018","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0690","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jcem-63-2-412","article-title":"Studies of hypothyroidism in patients with high iodine intake","volume":"63","author":"Tajiri","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0695","first-page":"67","article-title":"Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions","volume":"53","author":"Lewy-Trenda","year":"2002","journal-title":"Pol. J. Pathol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0700","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.biochi.2012.05.018","article-title":"Immunological functions of leptin and adiponectin","volume":"94","author":"Carbone","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0705","first-page":"2849","article-title":"Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage","volume":"82","author":"Garcia-Mayor","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0710","first-page":"645","article-title":"A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction","volume":"74","author":"Stagnaro-Green","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0715","first-page":"2494","article-title":"Evidence of fetal microchimerism in Hashimoto\u2019s thyroiditis","volume":"86","author":"Klintschar","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0720","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/endo.143.1.8563","article-title":"Intrathyroidal fetal microchimerism in pregnancy and postpartum","volume":"143","author":"Imaizumi","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0725","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1210\/jc.2011-3160","article-title":"Microchimerism and endocrine disorders","volume":"97","author":"Fugazzola","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0730","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(99)02429-0","article-title":"Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis","volume":"354","author":"Coles","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0735","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.beem.2009.07.003","article-title":"Immune reconstitution syndrome and the thyroid","volume":"23","author":"Weetman","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0740","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2018-00359","article-title":"Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features","volume":"103","author":"Pariani","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0745","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1089\/thy.2018.0232","article-title":"Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years","volume":"28","author":"Muller","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0750","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/thy.2004.14.1047","article-title":"Stress and thyroid autoimmunity","volume":"14","author":"Mizokami","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0755","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000074309","article-title":"Increase in serum levels of autoantibodies after attack of seasonal allergic rhinitis in patients with Graves\u2019 disease","volume":"132","author":"Takeoka","year":"2003","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0760","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0765","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(14)61396-9","article-title":"40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study","volume":"385","author":"Quaresma","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 10","key":"10.1016\/j.semcancer.2019.05.013_bib0770","doi-asserted-by":"crossref","first-page":"x207","DOI":"10.1093\/annonc\/mds326","article-title":"The current state of breast cancer classification","volume":"23","author":"Viale","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0775","series-title":"WHO Classification of Tumours of the Breast","author":"Lakhani","year":"2012"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0780","first-page":"52","article-title":"Essential clinical anatomy","author":"Moore","year":"2015","journal-title":"Wolters Kluwer Health"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0785","first-page":"149","volume":"8","author":"Sinn","year":"2013"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0790","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0795","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","article-title":"Prognostic factors in breast cancer. College of American pathologists consensus statement 1999","volume":"124","author":"Fitzgibbons","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0800","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/1097-0142(20010415)91:8+<1589::AID-CNCR1170>3.0.CO;2-K","article-title":"TNM: principles, history, and relation to other prognostic factors","volume":"91","author":"Sobin","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0805","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0810","first-page":"17","article-title":"Syed-sha-Qhattal H. Breast Cancer: conventional diagnosis and treatment modalities and recent patents and technologies","volume":"9","author":"Nounou","year":"2015","journal-title":"Breast Cancer (Auckl)"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0815","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0820","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10911-009-9116-x","article-title":"Stemming resistance to HER-2 targeted therapy","volume":"14","author":"Bedard","year":"2009","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0825","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/modpathol.3800453","article-title":"The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications","volume":"18","author":"Honrado","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0830","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.semcancer.2019.05.013_bib0835","doi-asserted-by":"crossref","first-page":"I7","DOI":"10.1093\/annonc\/mdh651","article-title":"Genetic alterations in hereditary breast cancer","volume":"15","author":"Cipollini","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0840","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jso.21856","article-title":"Translational advances regarding hereditary breast cancer syndromes","volume":"105","author":"Gage","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"Suppl 2","key":"10.1016\/j.semcancer.2019.05.013_bib0845","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1038\/bjc.2011.489","article-title":"16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010","volume":"105","author":"Parkin","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0850","first-page":"21","article-title":"Epidemiologic evidence for the increased cell proliferation model of carcinogenesis","volume":"369","author":"Preston-Martin","year":"1991","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0855","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/1097-0142(19951115)76:10+<2059::AID-CNCR2820761325>3.0.CO;2-1","article-title":"Hormones and breast cancer","volume":"76","author":"Helzlsouer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0860","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0865","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0870","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2015.05.026","article-title":"Meta-analysis of oral contraceptive use and risks of all-cause and cause-specific death","volume":"131","author":"Zhong","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0875","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0880","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/scbi.1999.0131","article-title":"The mitotic machinery as a source of genetic instability in cancer","volume":"9","author":"Pihan","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0885","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1667\/RR3082","article-title":"Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990","volume":"160","author":"Land","year":"2003","journal-title":"Radiat. Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0890","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/cncr.22656","article-title":"Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?","volume":"109","author":"Brody","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0895","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4236\/abcr.2012.13005","article-title":"Pesticides and breast cancer","volume":"1","author":"Ferro","year":"2012","journal-title":"Adv. Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nure.12083","article-title":"Breast cancer and dietary patterns: a systematic review","volume":"72","author":"Albuquerque","year":"2014","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0905","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13058-014-0446-2","article-title":"Risk determination and prevention of breast cancer","volume":"16","author":"Howell","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0910","first-page":"15","article-title":"Breast Cancer and its relationship with the microbiota","author":"Fernandez","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0915","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0920","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-04231-7_2","article-title":"Physical activity and breast cancer prevention","volume":"186","author":"Lynch","year":"2011","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0925","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.28989","article-title":"Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition","volume":"136","author":"Tsilidis","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0930","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights","volume":"28","author":"Samani","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0935","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/172460081002500305","article-title":"IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors","volume":"25","author":"Fiore","year":"2010","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0940","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1530\/ERC-11-0374","article-title":"Obesity, type 2 diabetes, and cancer: the insulin and IGF connection","volume":"19","author":"Cohen","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0945","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/920618","article-title":"The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms","volume":"2015","author":"Joung","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0950","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(01)72307-0","article-title":"On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases","volume":"2","author":"Beatson","year":"1896","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0955","first-page":"337","article-title":"Thyroid hormone for the prevention of postoperative recurrence of carcinoma of the female breast and genitalia. A review of 211 cases in a nine-year study","volume":"29","author":"Loeser","year":"1958","journal-title":"J. Int. Coll. Surg."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0960","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bmj.2.4901.1380","article-title":"A new therapy for prevention of post-operative recurrences in genital and breast cancer; a six-years study of prophylactic thyroid treatment","volume":"2","author":"Loeser","year":"1954","journal-title":"Br. Med. J."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0965","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0140-6736(74)90344-4","article-title":"Hypothalamic-pituitary-thyroid axis in breast cancer","volume":"1","author":"Mittra","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0970","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.20881","article-title":"Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma","volume":"103","author":"Cristofanilli","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0975","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/ijc.27470","article-title":"Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk","volume":"131","author":"Tosovic","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib0980","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/03009737909179159","article-title":"Thyroid function in breast cancer patients before and up to two years after mastectomy","volume":"84","author":"Adami","year":"1979","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0985","first-page":"1713","article-title":"Thyroid function in breast cancer patients","volume":"30","author":"Ditsch","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0990","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-86-4-502","article-title":"American thyroid association statement: breast cancer and thyroid hormone therapy","volume":"86","author":"Gorman","year":"1977","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib0995","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.1965.12","article-title":"Thyroid hormone as a prophylactic agent following radical treatment of breast cancer","volume":"19","author":"Lyons","year":"1965","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1000","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.1984.03340290030015","article-title":"Breast cancer in hypothyroid women using thyroid supplements","volume":"251","author":"Hoffman","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1055-9965.EPI-08-0911","article-title":"Thyroid function and cancer risk: a prospective population study","volume":"18","author":"Hellevik","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1010","first-page":"1093","article-title":"Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmo Diet and Cancer study","volume":"26","author":"Brandt","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study","volume":"174","author":"Sogaard","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-12-0564","article-title":"Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study","volume":"168","author":"Tosovic","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/1471-2407-14-536","article-title":"T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study","volume":"14","author":"Tosovic","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1030","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1210\/jc.2015-1874","article-title":"Cancer incidence and mortality in patients treated either with RAI or thyroidectomy for hyperthyroidism","volume":"100","author":"Ryodi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bjc.1985.99","article-title":"Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes","volume":"51","author":"Bruning","year":"1985","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0167-8140(00)00183-3","article-title":"Severe hypothyroidism after chemotherapy and locoregional irradiation for breast cancer","volume":"57","author":"Cutuli","year":"2000","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/B:BREA.0000010708.99455.e1","article-title":"Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?","volume":"83","author":"Kumar","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10549-014-3256-4","article-title":"Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)","volume":"149","author":"de Groot","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1055","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/cncr.23307","article-title":"Risk of hypothyroidism in older breast cancer patients treated with radiation","volume":"112","author":"Smith","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin\u2019s disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/00365519850186670","article-title":"Thyroid function in postmenopausal breast cancer patients treated with tamoxifen","volume":"58","author":"Anker","year":"1998","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1070","first-page":"150","article-title":"Thyroid function in postmenopausal women with breast cancer on tamoxifen","volume":"19","author":"Kostoglou-Athanassiou","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000011928","article-title":"Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer","volume":"56","author":"Zidan","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1080","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jso.21662","article-title":"Breast cancer surgery-induced immunomodulation","volume":"102","author":"Boomsma","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1085","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.7314\/APJCP.2014.15.16.6643","article-title":"Relationship between breast cancer and levels of serum thyroid hormones and antibodies: a meta-analysis","volume":"15","author":"Shi","year":"2014","journal-title":"Asian Pacific Journal of Cancer Prevention: Apjcp"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/BF03350810","article-title":"Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer","volume":"30","author":"Fiore","year":"2007","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1095","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2967\/jnumed.112.108811","article-title":"Incidental diffuse thyroid 18F-FDG uptake related to autoimmune thyroiditis may be a favorable prognostic factor in advanced breast cancer","volume":"53","author":"Kim","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1515\/cclm.2011.819","article-title":"Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer","volume":"50","author":"Farahati","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3892\/mco.2015.521","article-title":"Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer","volume":"3","author":"Kemal","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000460246","article-title":"TPOAb and thyroid function are not associated with breast Cancer outcome: evidence from a large-scale study using data from the taxotere as adjuvant chemotherapy trial (TACT, CRUK01\/001)","volume":"6","author":"Muller","year":"2017","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/EJE-11-0838","article-title":"Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysis","volume":"166","author":"Angelousi","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2008.11.015","article-title":"Molecular heterogeneity and alternative splicing of human lactoperoxidase","volume":"482","author":"Fragoso","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1125","first-page":"108","article-title":"Lactoperoxidase: structural insights into the function,ligand binding and inhibition","volume":"4","author":"Sharma","year":"2013","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/thy.2007.0122","article-title":"Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: evidence that chronic administration has no harmful effects","volume":"17","author":"Anguiano","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1135","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1677\/ERC-08-0125","article-title":"Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects","volume":"15","author":"Arroyo-Helguera","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/ERC-11-0065","article-title":"Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene-induced mammary tumors: association between lactoperoxidase and estrogen-adduct production","volume":"18","author":"Soriano","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193624","article-title":"Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines","volume":"13","author":"Godlewska","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1150","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1021\/tx049787n","article-title":"Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines","volume":"17","author":"Gorlewska-Roberts","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10534-006-0002-3","article-title":"A kinetic study on the lactoperoxidase catalyzed oxidation of estrogens","volume":"19","author":"Lovstad","year":"2006","journal-title":"Biometals"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/ERC-11-0065","article-title":"Antineoplastic effect of iodine and iodide in dimethylbenz[a]anthracene-induced mammary tumors: association between lactoperoxidase and estrogen-adduct production","volume":"18","author":"Soriano","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1165","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/endo-125-3-1211","article-title":"Relationship between immunological structure and biochemical properties of human thyroid peroxidase","volume":"125","author":"Ruf","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1170","first-page":"197","article-title":"Thyroid microsomal\/thyroid peroxidase autoantibodies show discrete patterns of cross-reactivity to myeloperoxidase, lactoperoxidase and horseradish peroxidase","volume":"67","author":"Banga","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1175","first-page":"1461","article-title":"Human monoclonal autoantibodies against the immunodominant region on thyroid peroxidase: lack of cross-reactivity with related peroxidases or thyroglobulin and inability to inhibit thyroid peroxidase enzymatic activity","volume":"80","author":"Nishikawa","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/eje.1.02205","article-title":"Detection of thyroid peroxidase mRNA and protein in orbital tissue","volume":"155","author":"Lai","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179066","article-title":"Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties","volume":"12","author":"Godlewska","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1190","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1387\/ijdb.113365jt","article-title":"Adipocyte is a non-trivial, dynamic partner of breast cancer cells","volume":"55","author":"Tan","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1195","first-page":"317","article-title":"Review: cancer-induced autoimmunity in the rheumatic diseases","volume":"67","author":"Shah","year":"2015","journal-title":"."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1200","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/78630","article-title":"The mammary gland iodide transporter is expressed during lactation and in breast cancer","volume":"6","author":"Tazebay","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1210","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2002-021544","article-title":"Immunohistochemical profile of the sodium\/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections","volume":"88","author":"Wapnir","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1215","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.bbrc.2006.08.170","article-title":"Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma","volume":"349","author":"Berger","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016023","article-title":"The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue","volume":"6","author":"Ryan","year":"2011","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"10.1016\/j.semcancer.2019.05.013_bib1225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10549-008-0059-5","article-title":"Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?","volume":"115","author":"Beyer","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EJE-08-0505","article-title":"Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers","volume":"160","author":"Peyrottes","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0969-8051(01)00243-8","article-title":"Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues","volume":"28","author":"Moon","year":"2001","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1240","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/1078-0432.CCR-04-0074","article-title":"The Na+\/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid","volume":"10","author":"Wapnir","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1245","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1210\/jcem.83.5.4839","article-title":"Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa","volume":"83","author":"Spitzweg","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2019.05.013_bib1250","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/BF03346281","article-title":"Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells","volume":"27","author":"Fierabracci","year":"2004","journal-title":"J. Endocrinol. Invest."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:36:38Z","timestamp":1760916998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19300434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":250,"alternative-id":["S1044579X19300434"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.013","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antigenic link between thyroid autoimmunity and breast cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}